您现在的位置: 首页> 研究主题> 核酶

核酶

核酶的相关文献在1989年到2022年内共计533篇,主要集中在肿瘤学、生物化学、基础医学 等领域,其中期刊论文370篇、会议论文14篇、专利文献149篇;相关期刊199种,包括生物化学与生物物理学报:英文版、医学分子生物学杂志、中华微生物学和免疫学杂志等; 相关会议14种,包括沪、苏、闽暨全军生物技术药物研讨会、中国环境诱变剂学会第13届学术交流会暨中国环境诱变剂学会青年学术交流会、首届北京地坛感染病学术会议等;核酶的相关文献由1107位作者贡献,包括张积仁、郑燕芳、金由辛等。

核酶—发文量

期刊论文>

论文:370 占比:69.42%

会议论文>

论文:14 占比:2.63%

专利文献>

论文:149 占比:27.95%

总计:533篇

核酶—发文趋势图

核酶

-研究学者

  • 张积仁
  • 郑燕芳
  • 金由辛
  • 李谨革
  • 连建奇
  • 周永兴
  • 屈艺
  • 赵永同
  • 韩金祥
  • 毛青
  • 期刊论文
  • 会议论文
  • 专利文献

搜索

排序:

年份

    • 翟文辉
    • 摘要: 根据细胞为内酶的化学本质将酶分为蛋白酶和核酶,介绍几种核酶在RNA加工中的特异性作用,从而在高中生物学教学中将两种不同类别的酶作明确区分,增强学生对酶的化学本质的理解,使学生在遇到具体问题时能够具体分析、作答,提高答题的正确率.
    • 邓莎; 董怡; 任尧; 邓锐杰; 何强
    • 摘要: 食品安全与人类健康息息相关.重金属污染已成为食品安全领域的突出问题,为保证食品安全,构建快速、廉价和可推广的食品重金属污染检测方法显得尤为重要.近年来,以功能核酸为基础的生物传感及分析技术引起了广泛关注.核酶和核酸适配体等功能核酸作为一种新型的生物识别分子,可实现对金属离子的特异性识别,在构建高灵敏、高选择性的食品重金属分析检测平台方面具有巨大的应用潜力.本文综述了功能核酸在重金属(铅、汞和镉)污染检测领域的应用进展,重点介绍了由功能核酸构建的荧光传感器和比色传感器,及功能核酸与纳米粒子复合构建的核酸纳米传感器.此外,考虑到食品重金属离子检测所涉及的区域范围广、样品数量多等问题,本文突出了功能核酸与微流控技术及便携检测设备整合的检测平台,为临场的食品重金属污染分析提供思路.
    • 单策; 李中瀚
    • 摘要: 为减少在CRISPR/Cas9基因编缉系统中,sgRNA通常由 Ⅲ 型启动子持续转录产生,Ⅲ 型启动子不易控制,sgRNA持续表达又容易产生细胞毒性这一缺陷,本文拟建立由 Ⅱ 型启动子转录,并由内含子中释放sgRNA的方法.我们在sgRNA的两端设计了三种"核酶-sgRNA-核酶"的组合,通过核酶的自剪切作用实现sgRNA的释放.实验结果表明,HHRz-sgRNA-HDVRz的设计能够正确的从内含子中释放sgRNA,并且该sgRNA在构建的copG-FP敲除模型中能够实现有效的基因编辑.这一发现证明在哺乳动物细胞中利用 Ⅱ 型启动子,在核酶和内含子剪切的协助下可以实现sgRNA的表达,这为Cas9和sgRNA整合在一个 Ⅱ型启动子之下实现组织特异性和药物诱导性表达提供了基础.
    • 马小龙; 李温斌; 辛志飞; 李殿坤; 周子凡; 万局易; 王坚刚
    • 摘要: BACKGROUND:Due to limited sources,poor hemocompatibility and poor anticoagulation performance,small-diameter tissue-engineered blood vessels cannot be applied in clinical practice.OBJECTIVE:To explore the physicochemical and mechanical properties of sheep carotid arteries after the decellularization in order to find appropriate materials for the preparation of tissue-engineered blood vessels.METHODS:Fresh carotid arteries from sheep were randomly divided into two groups:control group,in which,the sheep carotid arteries were cryopreserved for use after trimming and cleaning;experimental group,in which,after trimming and cleaning,the carotid arteries were decallularized by Triton X-100.sodium deoxycholate and EDTA for 24 hours,rinsed for 72 hours,digested with RNA/DNA enzymes for 24 hours,rinsed for 24 hours and reserved for later use.In both groups,blood samples were subjected to hematoxylin-eosin staining,collagen fiber staining,elastic fiber dyeing,and electron microscopy observation.The physical and chemical properties of the blood vessels are tested by tensile strength,wall tension and thickness.RESULTS AND CONCLUSION:(1) The collagen fibers in both two groups were neat and compact in alignment,with no obvious fracture.(2) Hematoxylin-eosin staining showed that:in the control group,the nuclei were distributed in the inner membrane,middle lamella and outer membrane of the vessels,and the fibers ran regularly;in the experimental group,the fibers ran in order but loosely,and there were no nuclei in the inner membrane,middle lamella and outer membrane of the vessels.(3) Elastic fibers in the control group were regular in alignment and mainly distributed in the middle lamella and outer membrane of the vessels,while in the experimental group,the elastic fibers ran regularly but loosely,and mainly distributed in the middle lamella and outer membrane of the vessels.(4) Under the scanning electron microscope,the originally formed vessels were observed in the experimental group,with no cell residues,and the collagen fibers ran orderly with no fracture and with uniform pore structure.(5) The vessel thickness was lower in the experimental group than the control group (P < 0.01),but the tensile strength showed no difference between the two groups,which was 46.55 kPa in the two groups.To conclude,the decelluarized sheep carotid artery can retain the necessary mechanical properties of the blood vessels after achieving the maximum removal of antigenicity.%背景:由于材料来源问题、材料血液相容性和抗凝性能不佳,致使小口径组织工程血管无法应用于临床.目的:探究经过脱细胞处理后绵羊颈动脉的理化性能及力学性能,为制备组织工程血管寻找合适材料.方法:获取新鲜离体绵羊颈动脉,分2组处理,对照组进行修剪及清洗处理,冻存备用;实验组进行修剪及清洗处理后,以Triton X-100+脱氧胆酸钠盐+EDTA进行脱细胞处理24 h,漂洗72 h,接着以RNA酶/DNA酶消化24 h,漂洗24 h后冻存备用.将两组血管进行苏木精-伊红染色、胶原纤维染色、弹力纤维染色及电镜扫描观察,检测血管的抗拉力强度、血管壁张力及厚度.结果与结论:①胶原纤维染色显示,对照组胶原纤维排列整齐,致密,无明显断痕;实验组胶原纤维排列整齐,致密,无明显断痕;②苏木精-伊红染色显示,对照组细胞核分布在血管的内膜、中层、外膜,纤维走行规则;实验组纤维走行规则,较松散,内膜、中层、外膜无明显细胞核分布;③弹力纤维染色显示,对照组弹力纤维分布规则,整齐,主要在于血管的中层及外膜;实验组弹力纤维走行规则,但较疏松,主要分布在于血管中层及外膜;④电镜扫描显示,实验组血管保持原有的形态,未见细胞结构残留,胶原纤维走行规则,连续性完整,孔隙结构较均匀;⑤实验组血管厚度低于对照组(P<0.01),两组拉力强度无差异,均可承受46.55 kPa的压力;⑥结果表明,经脱细胞处理的绵羊颈动脉,在最大程度去除抗原性的基础上保留了血管必要的力学性能.
    • 邓忠远; 李孝建; 侯海静; 张涛
    • 摘要: 目的 研究胰岛素样生长因子-Ⅰ(IGF-Ⅰ)及胰岛素样生长因子Ⅰ受体(IGF-ⅠR)核酶抑制病理性瘢痕形成的作用.方法 选取100只SPF级4~6周龄裸鼠,另选取2015年5月至2016年7月暨南大学医学院附属广州市红十字会医院18例烧伤整形科住院患者手术切除的组织病理性瘢痕标本.将瘢痕组织体外培养成纤维细胞并分为a~g 7组,分别转染IGF-Ⅰ及IGF-ⅠR核酶后,检测培养基上清中羟脯氨酸含量.利用real-time PCR检测IGF-Ⅰ及IGF-ⅠR mRNA水平.将小鼠随机分成A~H 8组,每组10只,分别散点注射不同浓度IGF-Ⅰ及IGF-ⅠR核酶后,检测瘢痕增生组织体积大小,应用内参物竞争性PCR定量分析裸鼠瘢痕组织中Ⅰ、Ⅲ型前胶原mRNA水平的改变.利用Western Immunoblotting法分析经处理后Ⅰ、Ⅲ型胶原蛋白水平的变化.结果 在成纤维细胞中转染不同浓度IGF-Ⅰ及IGF-ⅠR核酶后,上清中羟脯氨酸含量和IGF-Ⅰ、IGF-ⅠR mRNA水平均有所降低.单独转染IGF-ⅠR核酶及单独转染IGF-Ⅰ核酶对IGF-ⅠR mRNA水平无显著影响.在人增生性瘢痕裸鼠动物模型中注射IGF-Ⅰ及IGF-ⅠR核酶后,裸鼠瘢痕组织体积减小,瘢痕增生组织中Ⅰ型前胶原mRNA水平和蛋白水平降低,Ⅲ型前胶原mRNA水平和蛋白水平均有所增高.结论 IGF-Ⅰ及IGF-ⅠR核酶可用于治疗病理性瘢痕形成.%Objective To investigate the function of insulin-like growth factor-Ⅰ(IGF-Ⅰ) and insulin-like growth factor-Ⅰ receptor(IGF-ⅠR) ribozyme in inhibiting pathological scar formation.Methods To select 100 SPF grade 4 to 6 week-old nude mice, and to select another 18 cases of orthopedics in the department of burns and plastics, Guangzhou Red Cross hospital affiliated to Jinan university from May, 2015 to July, 2016 for histopathological scar specimens.The fibroblasts were cultured in vitro and divided into 7 groups.After transfection of IGF-Ⅰ and IGF-ⅠR ribozymes, the hydroxyproline content in the culture supernatant was detected.The mRNA levels of IGF-Ⅰ and IGF-ⅠR were detected by real-time PCR.The mice were divided into A to H groups (n=10 each) randomly.The IGF-Ⅰ and IGF-ⅠR ribozymes were injected at different concentrations.The size of hypertrophic scar was detected by competitive PCR and the changes of type Ⅰ and Ⅲ procollagen mRNA levels in scar tissue.The levels of type Ⅰ and Ⅲ collagen were analysed by Western immunoblotting.Results The expression of IGF-Ⅰ and IGF-ⅠR mRNA in supernatant were decreased after transfection of IGF-Ⅰ and IGF-ⅠR ribozymes in fibroblasts.The expression of IGF-ⅠR mRNA was not significantly affected by transfection of IGF-ⅠR ribozyme alone or IGF-Ⅰ ribozyme alone.The expression of procollagen mRNA and type Ⅰ procollagen mRNA in the hypertrophic scars of nude mice was significantly lower than that of the control group (P<0.05).The expression of procollagen mRNA Levels and protein levels were increased.Conclusion IGF-Ⅰ and IGF-ⅠR ribozyme can be used for the treatment of pathological scar formation.
    • 何军林
    • 摘要: 从基因组的双链DNA (dsDNA),到编码和非编码RNA(mRNA、lncRNA和miRNA等),只要与疾病发生相关,都可能作为基因治疗的靶标.这些靶标可被替换、修复、补充、抑制或消除,取决于所采取的具体基因治疗方法.基因编辑技术是将致病基因裁剪缝补为正常的基因,而化学合成的和体内表达的核酸药物则主要靶向致病性RNA.与此同时,转运核酸药物的方法也在大力研发中,包括病毒或质粒表达载体和各种聚合物材料.核酸药物的成药性、转运载体的安全性和效率是基因治疗方法面临的挑战性问题.本文简要综述近年来基因治疗药物,特别是反义核酸、核酶、脱氧核酶、小干扰RNA(siRNA)和微小RNA(miRNA)等化学合成的核酸药物,以及化学修饰在提高核酸药物的效价、抗酶解稳定性和有效转运等关键技术方面的进展.随着对基因调控在疾病发生过程中认识的逐步深入和核酸药物优化技术的进步,核酸药物的研发步伐将会越来越快,期待包括siRNA药物在内的更多核酸药物在不久的将来应用于临床治疗.
    • 周耕民; 刁勇; 李三暑
    • 摘要: 核酶是具有催化功能的结构性RNA分子,且大多数核酶具有剪切RNAs的功能,可以利用它们剪切信使RNA(mRNAs)调节基因表达,从而作为基因治疗的新手段.阐述核酶的发现历程,以及其在艾滋病、肝炎、肿瘤和生殖道系统感染等基因治疗的研究进展.最后,分析核酶在基因治疗中的技术优势及存在问题,并对核酶领域包括更多核酶晶体结构的确立、酶切机理的理解、核酶新的生物学功能的发现等研究进行展望.%Ribozymes are structured RNA molecules with catalytic activities.Since most ribozymes have the ability to cleave RNAs,they could be used to cleave mRNAs and regulate gene expression,and therefore becoming new tools for gene therapy.This paper describes the discovery history of ribozymes and their applications in the therapy researches of acquired immune deficiency syndrome,hepatitis,tumor,reproductive tract infection and other diseases.Lastly,the paper analyzes the technological advantages and the existing problems of the ribozyme's application in gene therapy,and looks into the future of researches on the establishment of more crystal structures of new ribozymes,understanding of ribozyme cleavage mechanisms,and the discovery of new biological functions of ribozymes.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号